Latest Tau protein Stories
TauRx Chairman Prof. Claude Wischik brings a clinical trial opportunity directly to caregivers and patients at breakfast event PHILADELPHIA and LONDON, Oct.
NEW YORK, June 30, 2014 /PRNewswire/ -- Oligomerix, Inc., a privately held company pioneering the development of disease
--Research Published in the Journal of Molecular Biology-- CAMBRIDGE, Mass., April 22, 2014 /PRNewswire/ -- Researchers from NeuroPhage
--Funds Will Advance Novel Approach for Treatment of Alzheimer's Disease and Other Diseases of Protein Aggregation-- CAMBRIDGE, Mass., March 25, 2014 /PRNewswire/ -- NeuroPhage Pharmaceuticals,
Former NBC Correspondent Robert Bazell to Give Keynote Address WHITE PLAINS, N.Y., Feb.
A stress-related protein genetically linked to depression, anxiety and other psychiatric disorders contributes to the acceleration of Alzheimer’s disease, a new study led by researchers at the University of South Florida has found.
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Two compounds found in cinnamon could play a role in delaying the onset of Alzheimer’s disease, and could even prevent the neurodegenerative condition, according to new research published online in The Journal of Alzheimer's Disease on Thursday.
- Pertaining to the surface or end opposite to the mouth in a radiate animal.